CVS to Cover Lilly's GLP-1 Medications, Expanding Access for Millions

CVS will soon cover Eli Lilly's GLP-1 medications, including Foundayo and Zepbound, potentially providing access to these drugs for millions more Americans.

28 May, 19:08 — 28 May, 19:08

Post Share

Sources

Showing 1 of 1 sources

marketwatchMostly Factual1d ago

Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.

By Jaimy Lee

Read full article →

PERSPECTA

PERSPECTA

CVS to Cover Lilly's GLP-1 Medications, Expanding Access for Millions

Sources

Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Yum! Brands Reportedly in Talks to Sell Pizza Hut to LongRange

Mumbai's Dabbawalas Face Decline Amid Remote Work and Rising Costs

Minho Region Embraces a Forward-Looking Vision for the Future

PERSPECTA